NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/18/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization158.32 mln
Float18.39 mln
Earnings Date08/04/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.13
Reliable
Relative Strength
5
/ 100
Severely lagging
Debt / Equity
2.04
Very high leverage
ROE
-108
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
CVRx develops and sells implantable medical devices designed to treat heart disease by stimulating nerves that help regulate the cardiovascular system. Its flagship product, Barostim, targets pressure-sensing receptors in the carotid artery to restore natural signaling between the heart and the nervous system. Founded in 2000 and based in Minneapolis, Minnesota, the company reaches patients across the United States and internationally through its own sales team as well as outside distributors.
